Aadi Bioscience Top Insiders

AADIDelisted Stock  USD 2.05  0.05  2.38%   
Aadi Bioscience employs about 53 people. The company is managed by 10 executives with a total tenure of roughly 124 years, averaging almost 12.0 years of service per executive, having 5.3 employees per reported executive. Assessment of Aadi Bioscience's management performance can provide insight into the firm performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Aadi Bioscience Management Team Effectiveness

The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.

Aadi Bioscience Workforce Comparison

Aadi Bioscience is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 4,161. Aadi Bioscience claims roughly 53.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.49.

Aadi Bioscience Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aadi Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aadi Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Aadi Bioscience insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aadi Bioscience Notable Stakeholders

An Aadi Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aadi Bioscience often face trade-offs trying to please all of them. Aadi Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aadi Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David LennonCEO PresidentProfile
Scott CPATreasurer, CFOProfile
Neil DesaiPresident, FounderProfile
Raymond SteitzSenior OfficerProfile
Bryan BallChief OperationsProfile
Marcy GrahamSVP CommunicationsProfile
Stephen JDSenior CounselProfile
Brendan MBAChief OfficerProfile
David DornanChief OfficerProfile
MD FACPChief OfficerProfile

About Aadi Bioscience Management Performance

The success or failure of an entity such as Aadi Bioscience often depends on how effective the management is. Aadi Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aadi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aadi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.

Aadi Bioscience Workforce Analysis

Traditionally, organizations such as Aadi Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aadi Bioscience within its industry.

Aadi Bioscience Manpower Efficiency

Return on Aadi Bioscience Manpower

Revenue Per Employee459.5K
Revenue Per Executive2.4M
Net Loss Per Employee1.2M
Net Loss Per Executive6.6M
Working Capital Per Employee1.9M
Working Capital Per Executive9.8M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Aadi Stock

If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data